Results 91 to 100 of about 44,698 (310)

EPO and Super-EPO: Erythropoietins Direct Neoangiogenesis by Cardiac Progenitor Cells [PDF]

Cell Stem Cell, 2011
Erythropoietin, the red blood cell-making cytokine, is also a potential cytoprotective agent in heart disease. In this issue of Cell Stem Cell, Hoch et al. (2011) use two heart failure models, including chemotherapeutic cardiotoxicity, to reveal a mechanistic connection between reduced cardiomyocyte production of erythropoietin and neoangiogenesis by ...
openaire   +2 more sources

Serum Epo concentrations.

, 2013
Serum Epo concentrations for individual mice (grey lines) and median (black line) of main experiment. The two samples per day on days 5 to 9 suggest diurnal oscillations.
William Chadwick (372029), Nicholas J. Savill (199898), Sarah E. Reece (228438)   +2 more
core   +1 more source

Assessing Surgical Extent in Endoscopic Sinus Surgery: A Scoping Review of Scoring Systems

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Endoscopic sinus surgery (ESS) varies substantially in the extent of surgical dissection performed, even when described under the same procedural label. In chronic rhinosinusitis, this heterogeneity may influence postoperative outcomes, revision rates, and response to biologic therapies.
Alexander Lein, Marie T. Ehrgott, Linda Liu, Archana Jaiswal, Rajiv K. Bhalla, Noel Ayoub, Faris F. Brkic, David T. Liu   +7 more
wiley   +1 more source

Effect of occasional epoetin use in combination with a stable darbepoetin dosage on anemia management in hemodialysis patients

ClinicoEconomics and Outcomes Research, 2014
Kazumasa Shimamatsu Shimamatsu Naika Iin (Clinic), Shiseikai Medical Corporation, Chikushino City, Japan Aim: Taking advantage of the characteristics of both darbepoetin (DA) and epoetin (EPO) might be a reasonable option for stabilizing hemoglobin (Hb)
Shimamatsu K
doaj  

EPO+G-CSF treatment induced angiogenesis.

, 2013
(A) Colocalization of GFP+ and vWF+ cells in transgenic GFP-chimeric mice treated with EPO+G-CSF was analyzed in the perivascular and endothelial regions of the ischemic hemispheres.
Shinn-Zong Lin (217003), Hsiao-Jung Wang (365701), Ren-Shyan Liu (170072), Shih-Ping Liu (292228), Woei-Cherng Shyu (308328), Demeral David Liu (365700), Hsu-Tung Lee (365699), Shin-Da Lee (54961)   +7 more
core   +1 more source

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss

, 2021
High erythropoietin (Epo) levels are detrimental to bone health in adult organisms. Adult mice receiving high doses of Epo lose bone mass due to suppressed bone formation and increased bone resorption.
Deepika Watts, Marta Murray, Gabet, Yankel, Hofbauer, Lorenz C., Drorit Neumann, Watts, Deepika, Thiele, Sylvia, Lorenz C. Hofbauer, Wielockx, Ben, Murray, Marta, Sylvia Thiele, Ben Wielockx, Martina Rauner, Yankel Gabet, Rauner, Martina, Neumann, Drorit   +15 more
core   +1 more source

Inflammatory Signatures Beyond Th1/Th2 Endotypes Provide Insights Into Postoperative Recurrence in Chronic Rhinosinusitis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis (CRS) represents a spectrum of inflammatory endotypes, driven by distinct T helper (Th) immune responses. The high rate of recurrent disease despite appropriate medical and surgical interventions highlights the need for improved characterization beyond the traditional type 2 and non‐type 2 phenotypes to better
Liyona Kampel, Narin N. Carmel, Shaun Edalati, Hen Chaushu, Forsan Jahshan, Yaniv Hadi, Timur Pestrikov, Leonor Leider Trejo, Nidal Muhanna, Avraham Abergel   +9 more
wiley   +1 more source

Physiology and pathophysiology of renal erythropoietin-producing cells

Journal of the Formosan Medical Association, 2018
Anemia is a common complication and contributes to increased morbidity and mortality in chronic kidney disease (CKD) patients. Whereas there has been a significant improvement of understanding the underlying mechanism of erythropoiesis, the treatment of ...
Hong-Mou Shih, Chih-Jen Wu, Shuei-Liong Lin   +2 more
doaj   +1 more source

Italian randomized trial of hemoglobin maintenance to prevent or delay left ventricular hypertrophy in chronic kidney disease.

, 2008
Background: This study is part of a 3-country study testing whether normal levels of hemoglobin (Hgb) delay the progression of left ventricular (LV) growth in chronic kidney disease (CKD) patients not on dialysis.
BARRETT BJ, ITA EPO 7 i.n.v.e.s.t.i.g.a.t.o.r.s., CIANCIARUSO B, PICCOLI, ANTONIO, LEVIN A, CIANCIARUSO, BRUNO, ITA EPO INVESTIGATORS, RAVANI P   +7 more
core  

EPO patent applications during 2023

, 2023
EPO patent applications during 2023 parsed from the EBD weekly files in XML ST36 format.
Thoma, Grid
core